Novavax to Share New Data from Growing Vaccine Portfolio at World Vaccine Congress Europe 2022
New safety and immunogenicity data for the COVID-19-Influenza Combination vaccine candidate Phase 1/2 trial will be presented New data will ...
New safety and immunogenicity data for the COVID-19-Influenza Combination vaccine candidate Phase 1/2 trial will be presented New data will ...
The MEA Times reports and aggregates business, Tech and lifestyle news on EMEA regions.
We provide press release distribution to media outlets in Africa, Middle East and Europe. Submit a press release or contact us today.